JP6599995B2 - ナノ粒子を製造するための方法及び装置 - Google Patents

ナノ粒子を製造するための方法及び装置 Download PDF

Info

Publication number
JP6599995B2
JP6599995B2 JP2017537021A JP2017537021A JP6599995B2 JP 6599995 B2 JP6599995 B2 JP 6599995B2 JP 2017537021 A JP2017537021 A JP 2017537021A JP 2017537021 A JP2017537021 A JP 2017537021A JP 6599995 B2 JP6599995 B2 JP 6599995B2
Authority
JP
Japan
Prior art keywords
pressure
nozzle
mixture
nanoparticles
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017537021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536983A (ja
JP2017536983A5 (enExample
Inventor
ハエッグストレーム エドワルド
ユリルーシ ヨウコ
ファルク カイ
ライッコネン ヘイッキ
ペッシ イェンニ
ラッシラ イルッカ
メリライネン アンッティ
Original Assignee
ナノフォーム フィンランド オサケユイチア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ナノフォーム フィンランド オサケユイチア filed Critical ナノフォーム フィンランド オサケユイチア
Publication of JP2017536983A publication Critical patent/JP2017536983A/ja
Publication of JP2017536983A5 publication Critical patent/JP2017536983A5/ja
Application granted granted Critical
Publication of JP6599995B2 publication Critical patent/JP6599995B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J3/00—Processes of utilising sub-atmospheric or super-atmospheric pressure to effect chemical or physical change of matter; Apparatus therefor
    • B01J3/008—Processes carried out under supercritical conditions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nanotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Optics & Photonics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Steroid Compounds (AREA)
JP2017537021A 2014-10-06 2015-10-05 ナノ粒子を製造するための方法及び装置 Active JP6599995B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20140266A FI20140266A7 (fi) 2014-10-06 2014-10-06 Menetelmä ja laite nanopartikkeleiden valmistamiseksi
FI20140266 2014-10-06
PCT/FI2015/050664 WO2016055696A1 (en) 2014-10-06 2015-10-05 A method and a device for producing nanoparticles

Publications (3)

Publication Number Publication Date
JP2017536983A JP2017536983A (ja) 2017-12-14
JP2017536983A5 JP2017536983A5 (enExample) 2018-10-25
JP6599995B2 true JP6599995B2 (ja) 2019-10-30

Family

ID=54540113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017537021A Active JP6599995B2 (ja) 2014-10-06 2015-10-05 ナノ粒子を製造するための方法及び装置

Country Status (10)

Country Link
US (1) US10098842B2 (enExample)
EP (1) EP3204150B1 (enExample)
JP (1) JP6599995B2 (enExample)
CA (1) CA2961107C (enExample)
DK (1) DK3204150T3 (enExample)
ES (1) ES2969055T3 (enExample)
FI (2) FI20140266A7 (enExample)
PL (1) PL3204150T3 (enExample)
PT (1) PT3204150T (enExample)
WO (1) WO2016055696A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641968B (zh) * 2016-01-07 2018-04-17 中国原子能科学研究院 一种具有在线光谱监测功能的超临界流体络合反应装置
FI127408B (en) 2016-09-29 2018-05-15 Nanoform Finland Oy Device, method and equipment for solubility testing
US11298668B2 (en) 2017-11-09 2022-04-12 Blh Ecology Concepts, Llc Process to produce nanoparticles
CN111012671B (zh) * 2019-11-25 2022-07-05 上海强德食品科技有限公司 一种微胶囊的物理制备方法
CN111215002B (zh) * 2020-01-20 2021-08-10 中南大学 高温高压超临界二氧化碳反应釜
FI129026B (en) 2020-01-29 2021-05-31 Nanoform Finland Oy System and method for producing particles of organic substances
EP3884930A1 (en) 2020-03-23 2021-09-29 Bayer AG Nano-dry-melting
CN111721495B (zh) * 2020-06-16 2022-02-08 中国人民解放军国防科技大学 一种新型纳米粒子平面激光散射实验的粒子生成装置
WO2024153733A1 (en) 2023-01-18 2024-07-25 Helm Ag Crystalline nanoparticles comprising enzalutamide
US12303845B2 (en) 2023-01-18 2025-05-20 Nanoform Finland Oyj Method for crystallization of active pharmaceutical ingredients
WO2025125509A1 (en) 2023-12-12 2025-06-19 Targtex S.A. Chemotherapeutic agent and compositions
WO2025153768A1 (en) 2024-01-18 2025-07-24 Nanoform Finland Oyj Composition comprising crystalline nanosized apalutamide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06102124B2 (ja) * 1985-12-27 1994-12-14 日本分光工業株式会社 超臨界流体による試料の分離回収方法
JP2774349B2 (ja) * 1990-03-17 1998-07-09 株式会社神戸製鋼所 微粒の製造方法
WO1997014407A1 (en) 1995-10-17 1997-04-24 Research Triangle Pharmaceuticals Insoluble drug delivery
JP3986086B2 (ja) 1996-03-01 2007-10-03 ザ ユニバーシティ オブ カンザス 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法
CA2294367A1 (en) * 1997-06-20 1998-12-30 Smithkline Beecham P.L.C. Treatment of a substance with a dense fluid (e.g. with a supercritical fluid)
US6177103B1 (en) 1998-06-19 2001-01-23 Rtp Pharma, Inc. Processes to generate submicron particles of water-insoluble compounds
FR2802445B1 (fr) * 1999-12-15 2002-02-15 Separex Sa Procede et dispositif de captage de fines particules par piegeage au sein d'un melange solide de type neige carbonique
US7279181B2 (en) 2003-06-03 2007-10-09 Ferro Corporation Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
US7754243B2 (en) 2004-08-03 2010-07-13 Clemson University Research Foundation Aqueous suspension of nanoscale drug particles from supercritical fluid processing
GB0525852D0 (en) * 2005-12-20 2006-02-01 Accentus Plc Crystallisation apparatus and process
JP2007301534A (ja) 2006-05-15 2007-11-22 Ebara Corp 微細化装置
US8585943B2 (en) * 2007-12-07 2013-11-19 Xspray Microparticles Ab Method and arrangement for the production of particles
JP5933234B2 (ja) * 2011-11-24 2016-06-08 国立大学法人東北大学 微粒子作製装置

Also Published As

Publication number Publication date
CA2961107A1 (en) 2016-04-14
EP3204150B1 (en) 2023-11-29
FI3204150T3 (fi) 2023-12-04
PL3204150T3 (pl) 2024-05-13
US10098842B2 (en) 2018-10-16
PT3204150T (pt) 2024-03-04
CA2961107C (en) 2023-01-03
US20170231914A1 (en) 2017-08-17
EP3204150A1 (en) 2017-08-16
ES2969055T3 (es) 2024-05-16
JP2017536983A (ja) 2017-12-14
FI20140266A7 (fi) 2016-04-07
WO2016055696A1 (en) 2016-04-14
DK3204150T3 (da) 2024-03-04

Similar Documents

Publication Publication Date Title
JP6599995B2 (ja) ナノ粒子を製造するための方法及び装置
JP3986086B2 (ja) 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法
Thakur et al. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process
Loh et al. Overview of milling techniques for improving the solubility of poorly water-soluble drugs
AU2009272444B2 (en) Process for improving crystallinity of fluticasone particles
US5851453A (en) Method and apparatus for the formation of particles
Türk et al. Formation and stabilization of submicron particles via rapid expansion processes
Tenorio et al. Controlled submicro particle formation of ampicillin by supercritical antisolvent precipitation
Thakur et al. Rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process: formation of 2-aminobenzoic acid nanoparticle
Bakhbakhi et al. Experimental study of the GAS process for producing microparticles of beclomethasone-17, 21-dipropionate suitable for pulmonary delivery
Foster et al. Application of dense gas techniques for the production of fine particles
Cai et al. Supercritical fluid assisted atomization introduced by hydrodynamic cavitation mixer (SAA-HCM) for micronization of levofloxacin hydrochloride
Sahakijpijarn et al. Pharmaceutical cryogenic technologies
Cares-Pacheco et al. Inverse gas chromatography a tool to follow physicochemical modifications of pharmaceutical solids: Crystal habit and particles size surface effects
Moribe et al. Micronization of phenylbutazone by rapid expansion of supercritical CO2 solution
Charpentier et al. Study of the RESS process for producing beclomethasone-17, 21-dipropionate particles suitable for pulmonary delivery
JP5358948B2 (ja) 粉末の被覆方法
JP7660577B2 (ja) 有機物質の粒子を製造するシステム及び方法
Zhiyi et al. Experimental investigation on the micronization of aqueous cefadroxil by supercritical fluid technology
Gadermann et al. Formation of naproxen–polylactic acid nanoparticles from supercritical solutions and their characterization in the aerosol phase
Bakhbakhi et al. Supercritical antisolvent synthesis of fine griseofulvin particles
Surasarang et al. Pharmaceutical cryogenic technologies
US8765184B2 (en) Method for preparing pharmaceutical compositions comprising fine particles of active substance
ES2366723T3 (es) Método y aparato para la precipitación y el recubrimiento de partículas utilizando antidisolventes cuasi-críticos y supercríticos.
Tian et al. Investigation of Physical Effects on Nanoparticle Size in Aerosol Solvent Extraction System

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180912

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180912

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190805

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190903

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191003

R150 Certificate of patent or registration of utility model

Ref document number: 6599995

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250